News Releases

All of the latest news about our university. (by topic)

UB engineers tapped for U.S. Space Force solar power project
10/4/24
Researchers will co-develop new photovoltaics to boost space propulsion and power systems.
Pulitzer finalist, Buffalo native Ed Park in town for UB’s Exhibit X fiction series
10/3/24
A founding editor of The Believer and former literary editor of The Village Voice, Park will discuss his latest novel, “Same Bed Different Dreams,” as well as his forthcoming debut story collection, “An Oral History of Atlantis.
Study: Canada and Australia making strides toward regulating predatory stem cell products
10/3/24
Oral biology professor documents their methods, hoping to replicate success in U.S.
UB philosopher awarded $3.8 million NIH grant on aging and loneliness
10/3/24
Team will create a publicly accessible online resource to promote healthy aging at the intersection of solitude and the sense of connection older adults feel as they age.
UB event to explore cellphone bans in schools, provide guidance for educators and parents
10/3/24
Oct. 10 event will explore the growing trend of banning cellphones in schools and its impact on students, educators and parents.
UB tops 30,000 in fall enrollment for sixth straight year
10/2/24
Total enrollment stands at 30,558 and includes a record 9,372 graduate students.
Bloomberg Businessweek ranks UB MBA No. 30 among public B-schools
10/2/24
Bloomberg Businessweek has again ranked the University at Buffalo School of Management’s MBA program one of the nation’s best.
Study: Stigma legitimizes unpaid labor as therapy, even for those doing the work
10/2/24
Rehab workers in the study who engaged in broad stigmatizing tropes about addiction were more likely to believe the “work therapy” — as it’s called by the Salvation Army — was beneficial.
UB expert Vincent Lynch says animal genes can help us understand human health
10/2/24
Evolutionary biologist joins Driven to Discover podcast to talk about his curiosity-driven research and why bringing back extinct species is a bad idea.
Study: For long COVID, lithium aspartate at low doses is ineffective, but higher doses may be promising
10/2/24
At low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID.